BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu WW, Lu M, Wang XY, Zhou X, Gao C, Qin LX. The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer. Genes Dis 2020;7:299-307. [PMID: 32884984 DOI: 10.1016/j.gendis.2020.01.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Mao L, Yuan X, Su J, Ma Y, Li C, Chen H, Zhang F. Human Umbilical Vein Endothelial Cells Survive on the Ischemic TCA Cycle under Lethal Ischemic Conditions. J Proteome Res 2022. [PMID: 36074008 DOI: 10.1021/acs.jproteome.2c00255] [Reference Citation Analysis]
2 Xie S, Pan J, Xu J, Zhu W, Qin L. The critical function of metabolic reprogramming in cancer metastasis. Aging and Cancer 2022;3:20-43. [DOI: 10.1002/aac2.12044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Duarte IF, Caio J, Moedas MF, Rodrigues LA, Leandro AP, Rivera IA, Silva MFB. Dihydrolipoamide dehydrogenase, pyruvate oxidation, and acetylation-dependent mechanisms intersecting drug iatrogenesis. Cell Mol Life Sci 2021;78:7451-68. [PMID: 34718827 DOI: 10.1007/s00018-021-03996-3] [Reference Citation Analysis]
4 Tong M, Wong TL, Zhao H, Zheng Y, Xie YN, Li CH, Zhou L, Che N, Yun JP, Man K, Lee TK, Cai Z, Ma S. Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer. Cell Rep 2021;36:109617. [PMID: 34433044 DOI: 10.1016/j.celrep.2021.109617] [Reference Citation Analysis]
5 Longo M, Paolini E, Meroni M, Dongiovanni P. Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC. Int J Mol Sci 2021;22:4173. [PMID: 33920670 DOI: 10.3390/ijms22084173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cokan KB, Urlep Ž, Lorbek G, Matz-Soja M, Skubic C, Perše M, Jeruc J, Juvan P, Režen T, Rozman D. Chronic Disruption of the Late Cholesterol Synthesis Leads to Female-Prevalent Liver Cancer. Cancers (Basel) 2020;12:E3302. [PMID: 33182326 DOI: 10.3390/cancers12113302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]